Publications by authors named "Lingguang Mu"

Claim this Profile
[
[Retracted] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.
Liyan Du, Xiaomei Li, Linhong Zhen, Weiling Chen, Lingguang Mu

Mol Med Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.
Liyan Du, Xiaomei Li, Linhong Zhen, Weiling Chen, Lingguang Mu

Mol Med Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis